MedTrace Logo

Moxibustion Reduces Symptoms and Improves Quality of Life in Patients With Allergic Rhinitis

NCT06173882 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-12-18

No results posted yet for this study

Summary

The objective of this randomized controlled clinical trial is to compare the therapeutic effect of moxibustion on allergic rhinitis. The main questions it aims to answer are:

Based on randomized controlled trials, verify the effectiveness of moxibustion in treating allergic rhinitis Based on a real-time monitoring system for human surface temperature, discuss the differences in therapeutic effects of different moxibustion doses on allergic rhinitis

Conditions

  • Allergic Rhinitis

Interventions

BEHAVIORAL

Ordinary moxibustion volume group

Moxibustion for 10 minutes per acupoint

BEHAVIORAL

First group of heavy moxibustion

Moxibustion for 20 minutes per acupoint

BEHAVIORAL

Second groups of heavy moxibustion

Moxibustion for 30 minutes per acupoint

Sponsors & Collaborators

  • Henan University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Yang Xie, MD · Henan University of Traditonal Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2024-08-01
Completion
2025-08-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06173882 on ClinicalTrials.gov